Compounds > mannitol
Page last updated: 2024-08-17

mannitol and Malaria

mannitol has been researched along with Malaria in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's5 (83.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnot, DE; Cavanagh, DR; Creasey, AM; Holder, AA; Longacre, S; Morgan, WD; Remarque, EJ; Sowa, MP; Thomas, AW1
Caro-Aguilar, I; Chitnis, CE; Galinski, MR; Lapp, S; McClure, H; Moreno, A; Shakri, AR; Strobert, E; Yazdani, SS1
Good, MF; Heppner, DG; Hirunpetcharat, C; Krieg, AM; Nitkumhan, T; Pichyangkul, S; Sakkhachornphop, S; Walsh, DS; Wipasa, J; Zheng, YZ1
Birkett, AJ; Calvo-Calle, JM; Dubovsky, F; Hensmann, M; Langermans, JA; Nardin, E; Schmidt, A; Thomas, AW; Thornton, GB; Vervenne, RA; Weiler, H1
Hirunpetcharat, C; Jeamwattanalert, P; Kittigul, L; Mahakunkijcharoen, Y; Mahannop, P; Pichyangkul, S1

Other Studies

6 other study(ies) available for mannitol and Malaria

ArticleYear
Comparative testing of six antigen-based malaria vaccine candidates directed toward merozoite-stage Plasmodium falciparum.
    Clinical and vaccine immunology : CVI, 2008, Volume: 15, Issue:9

    Topics: Adjuvants, Immunologic; Animals; Antibodies, Protozoan; Antigens, Protozoan; Baculoviridae; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique, Indirect; Immunoglobulin G; Malaria; Malaria Vaccines; Mannitol; Microbial Viability; Oleic Acids; Pichia; Plasmodium falciparum; Rabbits; Vaccines, Synthetic

2008
Preclinical assessment of the receptor-binding domain of Plasmodium vivax Duffy-binding protein as a vaccine candidate in rhesus macaques.
    Vaccine, 2008, Aug-12, Volume: 26, Issue:34

    Topics: Adjuvants, Immunologic; Aluminum Hydroxide; Animals; Antibodies, Protozoan; Antigens, Protozoan; Enzyme-Linked Immunosorbent Assay; Interferon-gamma; Lymphocytes; Macaca mulatta; Malaria; Malaria Vaccines; Mannitol; Oleic Acids; Protein Binding; Protozoan Proteins; Receptors, Cell Surface; Vaccines, Synthetic

2008
CpG oligodeoxynucleotide enhances immunity against blood-stage malaria infection in mice parenterally immunized with a yeast-expressed 19 kDa carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (MSP1(19)) formulated in oil-based Mo
    Vaccine, 2003, Jun-20, Volume: 21, Issue:21-22

    Topics: Adjuvants, Immunologic; Animals; Blotting, Western; CD4 Lymphocyte Count; CpG Islands; DNA; Female; Flow Cytometry; Immunoglobulin G; Malaria; Mannitol; Merozoite Surface Protein 1; Mice; Mice, Inbred BALB C; Oils; Oleic Acids; Oligodeoxyribonucleotides; Plasmodium yoelii; Recombinant Fusion Proteins; Saccharomyces cerevisiae; Vaccination

2003
Effect of adjuvant on reactogenicity and long-term immunogenicity of the malaria Vaccine ICC-1132 in macaques.
    Vaccine, 2005, Sep-30, Volume: 23, Issue:41

    Topics: Abscess; Adjuvants, Immunologic; Aluminum Hydroxide; Animals; Antibodies, Protozoan; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis B virus; Immunoglobulin G; Macaca mulatta; Malaria; Malaria Vaccines; Male; Mannitol; Models, Animal; Oleic Acids; Plasmodium falciparum; Protozoan Proteins; Viral Vaccines

2005
Long-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice.
    Clinical and vaccine immunology : CVI, 2007, Volume: 14, Issue:4

    Topics: Adjuvants, Immunologic; Animals; Antibodies, Protozoan; CpG Islands; Female; Malaria; Malaria Vaccines; Mannitol; Merozoite Surface Protein 1; Mice; Mice, Inbred BALB C; Oleic Acids; Oligodeoxyribonucleotides; Peptide Fragments; Plasmodium yoelii; Vaccines, Synthetic

2007
Cerebral malaria.
    Lancet (London, England), 1991, May-25, Volume: 337, Issue:8752

    Topics: Adult; Africa; Animals; Brain Diseases; Child; Humans; Intracranial Pressure; Malaria; Male; Mannitol; Middle Aged; Plasmodium falciparum; Spinal Puncture

1991